Indivior accused of multibillion-dollar fraud to boost opioid-treatment sales

Indivior accused of multibillion-dollar fraud to boost opioid-treatment sales

More reads

• The Theranos scandal has not spooked med-tech investors. (Financial Times)
• Indivior charged with conducting multibillion-dollar fraud to boost opioid-treatment sales. (STAT Plus)
• The biopharmaceutical cartel and high drug prices. (Forbes)
• Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality. (Endpoints)